TKIs had the great efficacy to inhibit the phosphorylation of tyrosine 1068, 1086, and 1145 of EGFR in the EGFR-mutant lung adenocarcinoma cells (Figure 5D). This evidence concerns the gene EGFR and lung adenocarcinoma.